Clin2
NCT07495202Possibly a fitRecruiting

Monkeypox vaccine trial for healthy adults

Health Volunteer

This trial tests a new monkeypox vaccine to see if it's safe and works. It's for healthy adults who haven't had monkeypox or smallpox before.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
180 people
Ages
18 years to 59 years
Study type
Interventional

Who can take part

  • Aged 18 to 59 years.
  • In good general health with no serious medical conditions.
  • No history of smallpox, monkeypox, or contact with someone infected with monkeypox.
  • No prior monkeypox vaccine.
  • Willing to prevent pregnancy for 6 months after the last dose.
  • Not allergic to any vaccine ingredients.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06771479Recruiting· Phase 1
Monkeypox vaccine safety and immune response study

This trial tests a new monkeypox vaccine to see if it is safe and helps the body build protection. It may be an option for adults who were born before 1980 and received a smallpox vaccine, or who meet other health criteria.

Zhengzhou, Henan
NCT05627713Recruiting
Studying monkeypox infection and vaccine in adults

This study looks at the medical and lab changes in people with suspected or likely monkeypox, and in adults who may be eligible for a monkeypox vaccine. Your participation helps researchers understand how infection and vaccination affect the body and how to improve care.

Paris
NCT05562323Recruiting
Study of immune response after monkeypox vaccination

This is an observational study that follows adults after they get a monkeypox vaccine to learn how their immune system responds. The results may help researchers understand what types of protection the vaccine creates.

Badalona, Barcelona
NCT07253675Not yet recruiting· Phase 2
Testing a new smallpox and mpox vaccine in the Democratic Republic of the Congo

This study tests a new vaccine designed to protect against smallpox and mpox. It aims to see if the vaccine is safe and triggers a good immune response in people aged 2 to 45.

NCT05654883Enrolling by invitation
Study of mpox immunity in people who were vaccinated or infected

This observational study looks at how your body’s defenses work against mpox (monkeypox), based on blood and health information. You may be eligible if you recently got an mpox vaccine or have had mpox infection and are now out of isolation.

New York, New York
NCT07379580Recruiting· Phase 2
Test of an mRNA vaccine for mpox in Africa

This trial tests a new mRNA vaccine to prevent mpox. It looks at how safe and effective the vaccine is in adults who have or haven't been exposed to mpox or similar viruses before.

Kinshasa

Hear when a new Health Volunteer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.